vs
M-tron Industries, Inc.（MPTI）与Varex Imaging Corp（VREX）财务数据对比。点击上方公司名可切换其他公司
Varex Imaging Corp的季度营收约是M-tron Industries, Inc.的14.7倍（$209.6M vs $14.2M）。M-tron Industries, Inc.净利率更高（24.1% vs 1.1%，领先23.0%）。M-tron Industries, Inc.同比增速更快（11.2% vs 4.9%）。M-tron Industries, Inc.自由现金流更多（$2.3M vs $-26.8M）。过去两年M-tron Industries, Inc.的营收复合增速更高（12.8% vs 0.8%）
M-tron Industries, Inc.是一家研发生产高性能频率控制与计时解决方案的企业，产品涵盖晶体振荡器、滤波器、集成计时组件等，主要服务航空航天、国防、电信、工业自动化、医疗设备领域，客户覆盖北美、欧洲及亚洲的商业和政府机构。
Varex Imaging是全球知名的影像组件及解决方案供应商，核心产品涵盖X射线管、数字平板探测器和图像处理软件，广泛应用于医疗诊断、放射肿瘤治疗及工业无损检测等领域，客户覆盖全球主要市场。
MPTI vs VREX — 直观对比
营收规模更大
VREX
是对方的14.7倍
$14.2M
营收增速更快
MPTI
高出6.2%
4.9%
净利率更高
MPTI
高出23.0%
1.1%
自由现金流更多
MPTI
多$29.1M
$-26.8M
两年增速更快
MPTI
近两年复合增速
0.8%
损益表 — Q4 2025 vs Q1 2026
| 指标 | | |
|---|---|---|
| 营收 | $14.2M | $209.6M |
| 净利润 | $3.4M | $2.3M |
| 毛利率 | — | 33.3% |
| 营业利润率 | 27.3% | 7.3% |
| 净利率 | 24.1% | 1.1% |
| 营收同比 | 11.2% | 4.9% |
| 净利润同比 | 60.1% | 866.7% |
| 每股收益（稀释后） | $0.90 | $0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MPTIVREX
| Q1 26 | — | $209.6M | ||
| Q4 25 | $14.2M | $228.9M | ||
| Q3 25 | $14.2M | $203.0M | ||
| Q2 25 | $13.3M | $212.9M | ||
| Q1 25 | $12.7M | $199.8M | ||
| Q4 24 | $12.8M | — | ||
| Q3 24 | $13.2M | $205.7M | ||
| Q2 24 | $11.8M | $209.1M |
净利润MPTIVREX
| Q1 26 | — | $2.3M | ||
| Q4 25 | $3.4M | $12.2M | ||
| Q3 25 | $1.8M | $-89.1M | ||
| Q2 25 | $1.6M | $6.9M | ||
| Q1 25 | $1.6M | $-300.0K | ||
| Q4 24 | $2.1M | — | ||
| Q3 24 | $2.3M | $-51.1M | ||
| Q2 24 | $1.7M | $1.4M |
毛利率MPTIVREX
| Q1 26 | — | 33.3% | ||
| Q4 25 | — | 34.0% | ||
| Q3 25 | — | 33.3% | ||
| Q2 25 | — | 36.0% | ||
| Q1 25 | — | 34.3% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 32.6% | ||
| Q2 24 | — | 32.0% |
营业利润率MPTIVREX
| Q1 26 | — | 7.3% | ||
| Q4 25 | 27.3% | 8.6% | ||
| Q3 25 | 18.0% | -39.8% | ||
| Q2 25 | 13.9% | 10.4% | ||
| Q1 25 | 15.8% | 5.6% | ||
| Q4 24 | 20.1% | — | ||
| Q3 24 | 22.1% | 5.3% | ||
| Q2 24 | 17.8% | 4.4% |
净利率MPTIVREX
| Q1 26 | — | 1.1% | ||
| Q4 25 | 24.1% | 5.3% | ||
| Q3 25 | 12.9% | -43.9% | ||
| Q2 25 | 11.7% | 3.2% | ||
| Q1 25 | 12.8% | -0.2% | ||
| Q4 24 | 16.7% | — | ||
| Q3 24 | 17.2% | -24.8% | ||
| Q2 24 | 14.8% | 0.7% |
每股收益（稀释后）MPTIVREX
| Q1 26 | — | $0.05 | ||
| Q4 25 | $0.90 | $0.29 | ||
| Q3 25 | $0.63 | $-2.15 | ||
| Q2 25 | $0.53 | $0.17 | ||
| Q1 25 | $0.56 | $-0.01 | ||
| Q4 24 | $0.68 | — | ||
| Q3 24 | $0.81 | $-1.25 | ||
| Q2 24 | $0.63 | $0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $20.9M | $125.6M |
| 总债务越低越好 | — | $367.6M |
| 股东权益账面价值 | $63.2M | $476.9M |
| 总资产 | $68.4M | $1.1B |
| 负债/权益比越低杠杆越低 | — | 0.77× |
8季度趋势，按日历期对齐
现金及短期投资MPTIVREX
| Q1 26 | — | $125.6M | ||
| Q4 25 | $20.9M | $155.1M | ||
| Q3 25 | $18.3M | $152.6M | ||
| Q2 25 | $15.5M | $223.0M | ||
| Q1 25 | $13.7M | $212.6M | ||
| Q4 24 | $12.6M | — | ||
| Q3 24 | $8.5M | $200.5M | ||
| Q2 24 | $6.5M | $190.0M |
总债务MPTIVREX
| Q1 26 | — | $367.6M | ||
| Q4 25 | — | $367.5M | ||
| Q3 25 | — | $367.5M | ||
| Q2 25 | — | $567.2M | ||
| Q1 25 | — | $567.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $443.4M | ||
| Q2 24 | — | $443.1M |
股东权益MPTIVREX
| Q1 26 | — | $476.9M | ||
| Q4 25 | $63.2M | $472.6M | ||
| Q3 25 | $37.0M | $455.3M | ||
| Q2 25 | $34.8M | $549.7M | ||
| Q1 25 | $33.2M | $540.2M | ||
| Q4 24 | $31.3M | — | ||
| Q3 24 | $26.2M | $529.1M | ||
| Q2 24 | $23.7M | $581.2M |
总资产MPTIVREX
| Q1 26 | — | $1.1B | ||
| Q4 25 | $68.4M | $1.1B | ||
| Q3 25 | $42.2M | $1.1B | ||
| Q2 25 | $39.7M | $1.4B | ||
| Q1 25 | $37.8M | $1.3B | ||
| Q4 24 | $36.6M | — | ||
| Q3 24 | $31.5M | $1.2B | ||
| Q2 24 | $28.4M | $1.3B |
负债/权益比MPTIVREX
| Q1 26 | — | 0.77× | ||
| Q4 25 | — | 0.78× | ||
| Q3 25 | — | 0.81× | ||
| Q2 25 | — | 1.03× | ||
| Q1 25 | — | 1.05× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.84× | ||
| Q2 24 | — | 0.76× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $2.7M | $-16.1M |
| 自由现金流经营现金流 - 资本支出 | $2.3M | $-26.8M |
| 自由现金流率自由现金流/营收 | 16.4% | -12.8% |
| 资本支出强度资本支出/营收 | 2.4% | 5.1% |
| 现金转化率经营现金流/净利润 | 0.78× | -7.00× |
| 过去12个月自由现金流最近4个季度 | $8.1M | $-13.3M |
8季度趋势，按日历期对齐
经营现金流MPTIVREX
| Q1 26 | — | $-16.1M | ||
| Q4 25 | $2.7M | $7.9M | ||
| Q3 25 | $3.5M | $7.7M | ||
| Q2 25 | $2.9M | $16.6M | ||
| Q1 25 | $1.6M | $9.5M | ||
| Q4 24 | $1.8M | — | ||
| Q3 24 | $2.3M | $25.9M | ||
| Q2 24 | $2.0M | $8.0M |
自由现金流MPTIVREX
| Q1 26 | — | $-26.8M | ||
| Q4 25 | $2.3M | $2.3M | ||
| Q3 25 | $2.7M | $1.4M | ||
| Q2 25 | $2.0M | $9.8M | ||
| Q1 25 | $1.0M | $5.3M | ||
| Q4 24 | $1.4M | — | ||
| Q3 24 | $1.8M | $19.9M | ||
| Q2 24 | $1.1M | $3.3M |
自由现金流率MPTIVREX
| Q1 26 | — | -12.8% | ||
| Q4 25 | 16.4% | 1.0% | ||
| Q3 25 | 19.1% | 0.7% | ||
| Q2 25 | 15.4% | 4.6% | ||
| Q1 25 | 8.0% | 2.7% | ||
| Q4 24 | 10.8% | — | ||
| Q3 24 | 13.4% | 9.7% | ||
| Q2 24 | 9.2% | 1.6% |
资本支出强度MPTIVREX
| Q1 26 | — | 5.1% | ||
| Q4 25 | 2.4% | 2.4% | ||
| Q3 25 | 5.7% | 3.1% | ||
| Q2 25 | 6.1% | 3.2% | ||
| Q1 25 | 4.6% | 2.1% | ||
| Q4 24 | 3.3% | — | ||
| Q3 24 | 3.6% | 2.9% | ||
| Q2 24 | 7.4% | 2.2% |
现金转化率MPTIVREX
| Q1 26 | — | -7.00× | ||
| Q4 25 | 0.78× | 0.65× | ||
| Q3 25 | 1.92× | — | ||
| Q2 25 | 1.83× | 2.41× | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.85× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 1.12× | 5.71× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MPTI
| US | $11.3M | 79% |
| Non Us | $2.9M | 21% |
VREX
| Medical Segment | $144.8M | 69% |
| Industrial Segment | $64.8M | 31% |
